We fight to improve the lives
of everyone affected by epilepsy

Warning message

  • This article was published in March 2017. The information may be out of date. Please check our epilepsy information or our site A-Z.
  • This article was published in February 2017. The information may be out of date. Please check our epilepsy information or our site A-Z.
  • This article was published in October 2016. The information may be out of date. Please check our epilepsy information or our site A-Z.
  • This article was published in June 2016. The information may be out of date. Please check our epilepsy information or our site A-Z.
  • This article was published in May 2016. The information may be out of date. Please check our epilepsy information or our site A-Z.

Stories about pregnancy

Exposure of babies to topiramate and valproate in womb linked to birth defects, study suggests

1 Jul 2019

A new study in Neurology has shown an increased risk of birth defects in babies born to mothers taking medicines valproic acid and topiramate.

Study authors Pierre-Olivier Blotière and colleagues wanted to look at risks of birth defects to babies being exposed to 10 different epilepsy medicines in pregnancy. They were lamotrigine, pregabalin, clonazepam, valproic acid, levetiracetam, topiramate, carbamazepine, gabapentin, oxcarbazepine and phenobarbital.

Topiramate may be linked to increased risk of birth defects in babies born to women taking the medicine

9 Jan 2018

TopirimateA new US study has found that taking the medicine topiramate during pregnancy may cause an increased risk of birth defects.

Topiramate is an epilepsy medicine sometimes used to treat generalised tonic-clonic seizures or focal seizures. This medicine can also be used for other conditions, such as bipolar disorder.

Pages

Subscribe to pregnancy